
Press releases
Find out more about Ferring latest announcements.
Press releases
- Uncategorized1
- TIMELINES35
- STATEMENT 20201
- STATEMENT 18 MARCH 20200
- PRESS RELEASE 20205
- PRESS RELEASE 20198
- PRESS RELEASE 201816
- PRESS RELEASE 201721
- PRESS RELEASE 201619
- PRESS RELEASE 201513
- PRESS RELEASE 201410
- PRESS RELEASE 20139
- PRESS RELEASE 20129
- PRESS RELEASE 20118
- PRESS RELEASE 20105
- PRESS RELEASE 200912
- PRESS RELEASE 20088
- PRESS RELEASE 20076
- PRESS RELEASE 20066
- PRESS RELEASE 20058
- PRESS RELEASE 200417
- PRESS RELEASE 200310
- PRESS RELEASE 200211
- PRESS RELEASE0
- Okategoriserad0
- NEWS0
- GENERAL0
- FEATURES0
- June 2020
- May 2020
- February 2020
- January 2020
- December 2019
- November 2019
- July 2019
- June 2019
- March 2019
- January 2019
- December 2018
- October 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- October 2015
- September 2015
- August 2015
- July 2015
- April 2015
- February 2015
- January 2015
- December 2014
Ferring and Igenomix collaborate to advance care in reproductive medicine and maternal health
- by sarvajeetFerring Pharmaceuticals and Igenomix today announced a two-year research collaboration aimed at the discovery of novel targets and disease mechanisms in infertility and pregnancy-related conditions, including preeclampsia, with the goal of developing innovative diagnostic and therapeutic strategies in these areas of high unmet need.
sarvajeetSwissmedic approves Carbetocin Ferring for the prevention of postpartum haemorrhage in all births
- by coborgFerring Pharmaceuticals today welcomes the Swissmedic approval of Carbetocin Ferring, a heat-stable formulation of carbetocin, for the prevention of excessive bleeding after childbirth following all births, both vaginal and caesarean section. Every year, 14 million women experience excessive bleeding after birth, also known as postpartum haemorrhage…
coborgRebiotix and Ferring announce world’s first with positive preliminary pivotal Phase 3 data for investigational microbiome-based therapy RBX2660
Today, Rebiotix and Ferring Pharmaceuticals announced positive preliminary findings from their ongoing pivotal Phase 3 trial of the investigational microbiome-based treatment, RBX2660. These preliminary positive efficacy findings mark an important milestone, advancing RBX2660 in its clinical…